Summary
Premature infants are vulnerable to infections, partly because of the low transplacental transfer of maternal antibodies. The present study investigated the placental transfer of maternal rubella-specific antibodies to full-term and preterm infants. The study group consisted of 133 healthy, native Israeli mothers and their 159 newborns. Of these, 69 were full-term infants (gestational age >37 weeks) of 69 mothers, and 90 were preterm infants (gestational age <35 weeks) of 64 mothers. Antibody titers against rubella were measured in maternal and umbilical cord blood samples by hemagglutination inhibition and microneutralization techniques. There was no significant difference in the level of protection and in geometrical mean titers by hemagglutination between the full-term and preterm groups. Conversely, significant differences in geometric mean titers of neutralizing antibodies were found between full-term and preterm infants, e.g., 65.9 and 39.8, respectively (P<0.001). Very low birth weight preterm infants are at greater risk of rubella infection during the first year of life, due to the diminished transfer of neutralizing maternal antibodies. Therefore, earlier vaccination of this group may be beneficial.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Horstmann, D. M., Liebhaber, H., Le Bouvier, G. L., Rosenberg, D. A., Halstead, S. B.: Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemio. N. Engl. J. Med. 283 (1970) 771–778.
Morgan-Capner, P.: Does rubella reinfection matter? In:Mortimer, P. P. (ed.) Public health virology, 12 reports. Public Health Laboratory Service, London 1986, pp. 50–62.
Robinson, J., Lemay, M., Vaudry, W. L.: Congenital rubella after anticipated maternal immunity: two cases and review of the literature. Pediatr. Infect. Dis. 13 (1994) 812–815.
Aboundy, Y., Fogel, A., Barnea, B., Mendelson, E., Yosef, L., Frank, T., Shalev, E.: Subclinical rubella reinfection during pregnancy followed by transmission of view to the fetus. J. Infect 34 (1997) 273–276.
Stewart, G. L., Parkman, P. D., Hopps, H. E., Douglas, R. D., Hamilton, J. P., Meyer, H. M. Jr.: Rubella virus haemagglutination-inhibition test. N. Engl. J. Med. 276 (1967) 554–557.
Fogel, A., Handsher, R., Barnea, B.: Subclinical rubella in pregnancy-occurrence and outcome. Isr. J. Med. Sci. 21 (1985) 133–138.
BMDP Statistical Software:Dixon, W. J. (ed.) University of California Press, Berkeley 1990.
Kohler, P. F., Farr, R. S.: Elevation of cord over maternal IgG immunoglobulin: evidence for active placental IgG transport. Nature 210 (1966) 1070–1071.
Evans, H. E., Akpata, S. O., Glass, L.: Serum immunoglobulin levels in premature and full term infants. Am. J. Clin. Pathol. 56 (1971) 416–418.
Asahi, T., Ueda, K., Hidaka, Y., Miyazaki, C., Tanaka, Y., Nishima, S.: Twenty three year follow up study of rubella antibodies after immunization in a closed population and serological response to revaccination. Vaccine 15 (1997) 1791–1795.
Gotlieb-Stematsky, T., Meron, I., Modan, M., Sayar, Y., Leventon-Kriss, S., Fogel, A., Gurewitz, R., Insler, V.: Viral antibodies in maternal and cord sera. Med. Microbiol. Immunol. 172 (1983) 67–74.
Sato, H., Albrecht, P., Reynolds, D. W., Stagno, S., Ennis, F. A.: Transfer of measles, mumps and rubella antibodies from mother to infant. Am. J. Dis. Child 133 (1979) 1240–1245.
Brouwer, R., de Groot, I. G., Verheij, F. B.: Comparison of maternal and cord serum titers for measles and rubella antibodies. Arch. Gesamte virusforsch. 44 (1974) 237–242.
Dennin, R. H., Husstedt, W.: (Specific antibodies to herpes simplex virus, cytomegalovirus and rubella virus: distribution in amniotic fluid and blood). Geburtshilfe-Frauenheilkd. 46 (1986) 873–876.
Suganuma, M., Kohno, S., Kohase, M., Shimizu, Y.: Occurrence of rubella virus lacking hemagglutination activity. Brief report. Arch. Gesamte Virusforsch. 29 (1970) 263–266.
Lennette, E. H., Schmidt, N. J., Maggofin, R. L.: The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status. J. Immunol. 99 (1967) 785–793.
Field, A. M., Vandervelde, E. M., Thompson, K. M., Hutchinson, D. N.: A comparison of the haemagglutination-inhibition test and the neutralisation test for the detection of rubella antibody. Lancet ii (1967) 182–184.
Schluederberg, A., Horstmann, D. M., Andiman, W. A., Randolph, M. F.: Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees naturally immune individuals. J. Infect. Dis. 138 (1978) 877–883.
National Committee for Clinical Laboratory Standards: Villaova, PA, 12 (1992) 1–3.
Skendzel, L. P.: Rubella immunity: defining the level of protective antibody. Am. J. Clin. Pathol. 106 (1996) 170–174.
Forsgren, M.: Standardization of techniques and reagents for the study of rubella antibody. Rev. Infect. Dis. 7 (1985) S129-S132.
Usonis, V., Bakasenas, V., Chitour, K., Clemens, R.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children. Infection 26 (1998) 222–226.
Singh, R., John, T. J., Cherian, T., Raghupathy, P.: Immune response to measles, mumps and rubella vaccine at 9, 12, and 15 months of age. Indian J. Med. Res. 100 (1994) 155–159.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linder, N., Sirota, L., Aboudy, Y. et al. Placental transfer of maternal rubella antibodies to full-term and preterm infants. Infection 27, 203–207 (1999). https://doi.org/10.1007/BF02561529
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02561529